In brief news today there is more on Fosamax (this time being associated with a risk for esophageal cancer) and on CureVac’s early stage trial of CV9103. In a Letter to the Editor of the New Eng… more →
THE "NEW" PROSTATE CANCER INFOLINKorthopedix wrote 3 months ago: Potential approach with BPs may be associated with thiazide diuretics or indapamide in the managemen … more →
Jim Tucker wrote 6 months ago: JUNE 9: NEW PROSTATE CANCER INFO-LINK: The risk of bisphosphonate-related osteonecrosis of the jaw i … more →
healthspanlife wrote 10 months ago: Again we must ask: why are patients with cancer, let alone those with “simply” osteopor … more →
Sitemaster wrote 11 months ago: In brief news today there is more on Fosamax (this time being associated with a risk for esophageal … more →
Sitemaster wrote 11 months ago: There has been a lot of media noise in the past few days about two studies suggesting that a drug ca … more →
Sitemaster wrote 1 year ago: The current report covers news from last Thursday through this morning. (Your editor needed a couple … more →
hijadoo wrote 1 year ago: U.S. BRAND NAMES — Fosamax Plus D™PHARMACOLOGIC CATEGORY Bisphosphonate DerivativeVitamin D AnalogDO … more →
hijadoo wrote 1 year ago: U.S. BRAND NAMES — Fosamax®PHARMACOLOGIC CATEGORY Bisphosphonate DerivativeDOSING: ADULTS — Note: Pa … more →
menspills wrote 2 years ago: Bisphosphonates are approved to treat osteoporosis in both men and postmenopausal women, in osteopor … more →